BSP Medical

BSP Medical is a biomedical technology company that develops noninvasive solutions for the diagnosis of cardiac diseases. BSP offers a range of electrocardiogram (ECG) products based on its HyperQ technology, including complete systems for routine clinical use, research-oriented systems, and OEM products. Its research systems facilitate data analysis by exporting all test parameters and measurements in a configurable format via a user-friendly, web-based interface. BSP's HyperQ Analyzer Stress is a software module designed to analyze stress-test ECGs based on the detection of changes in the high-frequency component of the QRS segment. HyperQ can be integrated into any ECG stress system or applied to big data. The company's HyperQ Analyzer Rest is a software module for the early detection of acute coronary artery disease on resting ECG systems. It facilitates the diagnosis of non-ST-elevation myocardial infarction and unstable angina. BSP Medical is a wholly owned subsidiary of Israel China Biotechnology Investments.

BSP Medical was founded in 2018 by Amir Beker (Founder & CEO).

BSP Medical operates in Health Tech & Life Sciences, Digital Healthcare, Digital Medical Diagnostics, with core technologies in Semiconductors & Electronics, Digital Signal Processor. Target customers: Healthcare & Life Sciences, Healthcare, Providers.

BSP Medical is based in HaBarzel St 30, Tel Aviv, Israel, Center District. The company also has offices abroad.